HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS
LATEST UPDATES » Vol 25, No. 01, January 2021 – Home-Based Diagnostic Testing: Revolutionizing IBD Treatment       » Study Reveals Understanding of China’s Carbon Emission Balance       » Developing Nanomaterials for Better Performance       » Helping Farmers Monitor Plant Health and Improve Crop Yield       » Protecting the Brain through Gut-Trained Immune Cells       » Using Machine Learning to Predict Anti-Cancer Drug Efficacy      
NEWS CRUNCH
Sanner receives Zero Defect Award
GSK honors Sanner of China as outstanding supplier

By awarding Sanner Pharmaceutical & Medical Packaging Materials (Kunshan) Co., Ltd. with the Zero Defect Award, GlaxoSmithKline (GSK) China recognized Sanner's outstanding performance in 2016 regarding quality. Sanner of China delivered five million sets of packaging materials to GSK during the last year without a single quality complaint. Furthermore, Sanner is the only GSK supplier out of a total of 150 with an OTIF level of 100 per cent. "Behind these numbers, this supplier made every effort on continuous improvement in quality, training and production," the jury underlined its decision.

On-site quality control for high-end products

"This award again proves the continuously high quality we maintain at our production site here in Kunshan," says Ralf Tiemann, Managing Director Sanner Kunshan China. Sanner of China carries out permanent on-site quality controls based on a six-step process. It includes incoming inspections of raw materials and supplier audits, followed by in-process quality control of the entire manufacturing process and full traceability. Regular process parameter controls ensure stable product quality, and each batch undergoes a customer-specific Operational Quality Control (OQC) before delivery.

"Together with internal audits and daily analysis meetings, we ensure that every single product we deliver to our customers conforms 100 per cent to their specifications, GMP guidelines and regulatory requirements," Tiemann underlines.

Expanding cleanroom capacities

During the past years, Sanner has invested significantly in the production site in Kunshan. Since February 2017, 200 additional square meters of production space are available at the site. However, Sanner does not rest on its laurels: "The past years' successful business results and our excellent future prospects in Asia will require continuous capacity expansions over the coming years," says Ralf Tiemann. Upon completion of the second construction phase, the company will be able to produce in 2,700 square meters of cleanroom space.

NEWS CRUNCH  
news Highlights from the E&L China 2020 Conference
news Asia’s ageing population drives development of rehabilitation technologies targeting elderly disabilities
news Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market
news WEIPU, AstraZeneca, Huadong Medicine, Saint-Gobain, Baxter, Wuxi AppTec, Henlius, Medtronic and more confirmed to speak at E&L China this December
SPOTLIGHT  

MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Contribute to APBN
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Deborah Seah
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2021 World Scientific Publishing Co Pte Ltd  •  Privacy Policy